DRUG

temozolomide

3 hypotheses across 2 therapeutic domains

ALL HYPOTHESES

Repurposing candidates for temozolomide

Inflammatory bowel disease 1

Mediator Outcome Score Tier Lit. status Trial
PD-L1 colitis 0.220 Mid reproduces known none

Pancreatic cancer 2

Mediator Outcome Score Tier Lit. status Trial
PD-L1 poor differentiation 0.220 Mid partial evidence none
PD-L1 type 2 autoimmune pancreatitis 0.220 Mid novel signal none

Clinical trials

200 registered trials for temozolomide

Source: ClinicalTrials.gov